About StemCyte
StemCyte is a company based in Covina (United States) founded in 1997. StemCyte has raised $23.25 million across 6 funding rounds from investors including unknown. The company has 43 employees as of December 31, 2022. StemCyte operates in a competitive market with competitors including China Cord Blood, Generate, LaCell, Forever Labs and Provia Labs, among others.
- Headquarter Covina, United States
- Employees 43 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stemcyte, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.25 M (USD)
in 6 rounds
-
Latest Funding Round
$2.5 M (USD), Debt – Conventional
Nov 22, 2010
- Investors
-
Employee Count
43
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of StemCyte
StemCyte has successfully raised a total of $23.25M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.5 million completed in November 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in StemCyte
StemCyte has secured backing from 1 investor. Prominent investors backing the company include unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|
Investor details for StemCyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StemCyte
Investment portfolio details for StemCyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - StemCyte
Detailed financials for StemCyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stemcyte Comparisons
Peer comparison for StemCyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of StemCyte
StemCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as China Cord Blood, Generate, LaCell, Forever Labs and Provia Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| Locked | Locked | Locked |
Provider of services for the storage of stem cells
|
|
| Locked | Locked | Locked |
Stem Cell Production
|
|
| Locked | Locked | Locked |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| Locked | Locked | Locked |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
Detailed competitors of StemCyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stemcyte
Complete news archive for StemCyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StemCyte
StemCyte was founded in 1997 and raised its 1st funding round 5 years after it was founded.
StemCyte is headquartered in Covina, United States. It is registered at Covina, California, United States.
StemCyte is a funded company, having raised a total of $23.25M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at StemCyte is 43.
StemCyte was founded in 1997 and focuses on umbilical cord blood stem cell transplantation and therapeutic products. Cord blood products are delivered to transplant centers for treating blood cancers, immune disorders, and genetic conditions. Storage facilities are maintained in California and Taiwan, with operations spanning the United States, India, and Taiwan. Headquarters are located in Covina, California, supporting global access to these medical resources.
StemCyte's top competitors include Forever Labs, China Cord Blood and LaCell.
StemCyte has 1 investor. Key investors include unknown.